CN1850220A - Medicine composition for treating urinary system stone and inflammation - Google Patents
Medicine composition for treating urinary system stone and inflammation Download PDFInfo
- Publication number
- CN1850220A CN1850220A CNA2006100587675A CN200610058767A CN1850220A CN 1850220 A CN1850220 A CN 1850220A CN A2006100587675 A CNA2006100587675 A CN A2006100587675A CN 200610058767 A CN200610058767 A CN 200610058767A CN 1850220 A CN1850220 A CN 1850220A
- Authority
- CN
- China
- Prior art keywords
- herba
- semen
- calculus
- component
- weight portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The present invention relates to a Chinese medicine composition for effectively curing lithiasis of urinary system and inflammation of urinary system. Said Chinese medicine composition includes, 8 Chinese medicinal materials of moneywort, knotgrass, mutong stem, alisma tuber, plantago seed, mallow seed and others. Its cure rate is high.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of pharmaceutical composition for the treatment of urinary system calculus and Urinary system inflammation.
Background technology
Calculus is a common frdquently encountered disease, and pathogenic factor mainly contains region water and soil, living and diet custom, factors such as individual physique.Iithiasic sickness rate is year by year and increases clinical cholelithiasis more commonly and urinary system calculus.Cholelithiasis shows as generally that upper abdomen is painful, support is expanded, appetite is low, have the hiccups, the acid of the right back back of the body is bloated, fear of cold heating what is more, nausea and vomiting, jaundice etc.; Urinary system calculus shows as the waist distending pain, kidney district angor, dysurea, urgent micturition, hematuria, dysuria etc.If treat untimelyly, severe patient can cause organ functions such as liver, kidney incomplete, threat to life.
Present Iithiasic Therapeutic Method is various, its most medical expense height, and holding time is long, just not saying cause loss economically, in the difficult therapeutic process of healing of delay the patient is satisfied and is tortured with a disease, and cure back relapse rate height.
Urinary system inflammation also is a common frdquently encountered disease.The prostatitis overwhelming majority occurs in person between twenty and fifty, and prostatitis can be divided into acute and chronic two kinds clinically.Acute prostatitis is more rare clinically, and chronic prostatitis morbidity in the crowd that grows up is higher, because of chronic prostatitis many with seminal vesiculitis, so be called prostatovesticulitis again.Urinary system inflammation is difficult to treatment and relapse rate height.
Summary of the invention
Deficiency in present urinary system calculus and the Urinary system inflammation treatment the invention provides a kind of pharmaceutical composition, is used for the treatment of urinary system calculus and Urinary system inflammation.
Technical scheme of the present invention is as follows:
The invention provides a kind of pharmaceutical composition, the component that comprises and the weight portion of each component are as follows:
Herba Lysimachiae 27-33; holds 12-18; Caulis Akebiae 3-9; Rhizoma Alismatis 7-13;
Semen Plantaginis 9-15; Semen Abutili 7-13; Herba Taraxaci 27-33; Herba Dianthi 7-13;
Talcum 27-33; Spora Lygodii 9-15; Herba Artemisiae Anomalae 9-15; Succinum 9-15;
Radix Achyranthis Bidentatae 12-18; Olibanum 7-13; Endothelium Corneum Gigeriae Galli 9-15; Catharsii molossi 3-9;
Semen Vaccariae 9-15; Carapax Trionycis 12-18.
As optimization, pharmaceutical composition provided by the invention, the component that comprises and the weight portion of each component are as follows:
Herba Lysimachiae 30; holds 15; Caulis Akebiae 6; Rhizoma Alismatis 10;
Semen Plantaginis 12; Semen Abutili 10; Herba Taraxaci 30; Herba Dianthi 10;
Talcum 30; Spora Lygodii 12; Herba Artemisiae Anomalae 12; Succinum 12;
Radix Achyranthis Bidentatae 15; Olibanum 10; Endothelium Corneum Gigeriae Galli 12; Catharsii molossi 6;
Semen Vaccariae 12; Carapax Trionycis 15.
The present invention also provides the preparation method of aforementioned pharmaceutical compositions as follows:
After grinding, each component of getting following weight portion is mixed and made into suitable dosage form,
Herba Lysimachiae 27-33; holds 12-18; Caulis Akebiae 3-9; Rhizoma Alismatis 7-13;
Semen Plantaginis 9-15; Semen Abutili 7-13; Herba Taraxaci 27-33; Herba Dianthi 7-13;
Talcum 27-33; Spora Lygodii 9-15; Herba Artemisiae Anomalae 9-15; Succinum 9-15;
Radix Achyranthis Bidentatae 12-18; Olibanum 7-13; Endothelium Corneum Gigeriae Galli 9-15; Catharsii molossi 3-9;
Semen Vaccariae 9-15; Carapax Trionycis 12-18.
As optimization, preparation of drug combination method provided by the invention is as follows:
After grinding, each component of getting following weight portion is mixed and made into suitable dosage form,
Herba Lysimachiae 30; holds 15; Caulis Akebiae 6; Rhizoma Alismatis 10;
Semen Plantaginis 12; Semen Abutili 10; Herba Taraxaci 30; Herba Dianthi 10;
Talcum 30; Spora Lygodii 12; Herba Artemisiae Anomalae 12; Succinum 12;
Radix Achyranthis Bidentatae 15; Olibanum 10; Endothelium Corneum Gigeriae Galli 12; Catharsii molossi 6;
Semen Vaccariae 12; Carapax Trionycis 15.
Described suitable dosage form can be any in tablet, powder, capsule and the pill.
Pharmaceutical composition provided by the invention can be used for renal calculus, ureteral calculus, vesical calculus, calculus of urethra and urethritis, cystitis, prostatitic treatment.
Herba Lysimachiae, in the prescription holds, Caulis Akebiae, Rhizoma Alismatis, Semen Plantaginis, Semen Abutili, Herba Taraxaci, Herba Dianthi, Talcum, Spora Lygodii clearing away heat and promoting diuresis, eliminating fire and detoxication, Tonglin Paishi, controls diseases such as " sand Stranguria ", " stranguria caused by urinary stone ", " stranguria with blood ".It is descending that sand Stranguria, stranguria with blood, pains in the penis, priming power are controlled in Herba Artemisiae Anomalae, Semen Vaccariae, succinum promoting blood circulation and breaking stagnation, diuresis relieving constipation, the stone of relieving oedema or abdominal distension through diuresis or purgation down, the treating stranguria blood stasis dispelling of Radix Achyranthis Bidentatae.The caused waist abdomen of calculus pain is subsided a swelling, is controlled in Olibanum regulating qi and activating blood, analgesic therapy.Endothelium Corneum Gigeriae Galli removing food stagnancy fossil.The relieving constipation of Catharsii molossi removing blood stasis with potent drugs, control the stranguria with turbid discharge calculus.Carapax Trionycis hard masses softening and resolving, fossil is treating stranguria.Full side cooperates the merit of playing promoting blood circulation and breaking stagnation, hard masses softening and resolving, eliminating fire and detoxication, clearing away heat and promoting diuresis, calculus dissolving and excreting altogether, makes the calculus discharge of being dissipated, and inflammation is eliminated, all disease spontaneous recovery.
The clinical application effect of pharmaceutical composition provided by the present invention is as follows:
Pharmaceutical composition provided by the present invention is used for the treatment of urinary system calculus and Urinary system inflammation, have no side effect, lithagogue effect significantly, short treating period, cure rate height, and cure the back and be difficult for recurrence.
The specific embodiment
Embodiment 1:
The component that the prescription of the pharmaceutical composition that present embodiment adopted comprises and the weight portion of each component are as follows:
Herba Lysimachiae 30; holds 15; Caulis Akebiae 6; Rhizoma Alismatis 10;
Semen Plantaginis 12; Semen Abutili 10; Herba Taraxaci 30; Herba Dianthi 10;
Talcum 30; Spora Lygodii 12; Herba Artemisiae Anomalae 12; Succinum 12;
Radix Achyranthis Bidentatae 15; Olibanum 10; Endothelium Corneum Gigeriae Galli 12; Catharsii molossi 6;
Semen Vaccariae 12; Carapax Trionycis 15.
According to the weight portion weighing medical material of each component in the prescription, grind the back and mix, adopt the conventional method of Chinese medicine preparation to be prepared into powder, packing aliquot, every part 3 gram.
The clinical patients statistics: the powder agent medicine that utilizes present embodiment to provide is treated 60 routine patients, and all patients all make a definite diagnosis through hospital.Wherein, renal calculus patient's 18 examples, ureteral calculus 12 examples, vesical calculus 13 examples, calculus of urethra 10 examples, urethritis 2 examples, cystitis 2 examples, prostatitis 3 examples.
Usage and dosage: three times on the one, one time nine gram, half an hour ante cibum warm water delivery service.15 is a course of treatment.Continue after the remission to take medicine and consolidate curative effect a course of treatment.
Irritable food such as period in a medicine is quitted smoking, the pungent work heat of wine and polydipsia water, multi-activity are beneficial to calculus and discharge.Be not taken by pregnant women, the old man child is cut down according to the circumstance.
Therapeutic effect: 60 routine clinical patients are being taken all recoveries from illness after three courses of treatment of this medicine continuously, and do not see recurrence so far.
Embodiment 2:
The component that the prescription of pharmaceutical composition that present embodiment adopts comprises and the weight portion of each component are as follows:
Herba Lysimachiae 27; holds 12; Caulis Akebiae 3; Rhizoma Alismatis 10;
Semen Plantaginis 9; Semen Abutili 7; Herba Taraxaci 27; Herba Dianthi 10;
Talcum 27; Spora Lygodii 9; Herba Artemisiae Anomalae 9; Succinum 9;
Radix Achyranthis Bidentatae 12; Olibanum 13; Endothelium Corneum Gigeriae Galli 10; Catharsii molossi 5;
Semen Vaccariae 10; Carapax Trionycis 12.。
According to the weight portion weighing medical material of each component in the prescription, grind the back and mix, adopt the conventional method of pharmaceutical preparation to be prepared into capsule, every 3 gram.
The clinical patients statistics: the powder agent medicine that utilizes present embodiment to provide is treated 51 routine patients, and all patients all make a definite diagnosis through hospital.Wherein, renal calculus patient's 11 examples, ureteral calculus 13 examples, vesical calculus 10 examples, calculus of urethra 10 examples, urethritis 2 examples, cystitis 2 examples, prostatitis 3 examples.
Usage and dosage: three times on the one, one time nine gram, half an hour ante cibum warm water delivery service.15 is a course of treatment.Continue after the remission to take medicine and consolidate curative effect a course of treatment.
Irritable food such as period in a medicine is quitted smoking, the pungent work heat of wine and polydipsia water, multi-activity are beneficial to calculus and discharge.Be not taken by pregnant women, the old man child is cut down according to the circumstance.
Therapeutic effect: 51 routine clinical patients are being taken all recoveries from illness after three courses of treatment of this medicine continuously, and do not see recurrence so far.
Embodiment 3:
The component that the prescription of Chinese medicine composition that present embodiment adopts comprises and the weight portion of each component are as follows:
Herba Lysimachiae 33; holds 15; Caulis Akebiae 7; Rhizoma Alismatis 7;
Semen Plantaginis 12; Semen Abutili 13; Herba Taraxaci 30; Herba Dianthi 7;
Talcum 33; Spora Lygodii 12; Herba Artemisiae Anomalae 15; Succinum 10;
Radix Achyranthis Bidentatae 15; Olibanum 12; Endothelium Corneum Gigeriae Galli 15; Catharsii molossi 9;
Semen Vaccariae 9; Carapax Trionycis 15.
According to the weight portion weighing medical material of each component in the prescription, grind the back and mix, adopt the conventional method of Chinese medicine preparation to be prepared into pill, every ball 3 grams.
The clinical patients statistics: the powder agent medicine that utilizes present embodiment to provide is treated 52 routine patients, and all patients all make a definite diagnosis through hospital.Wherein, renal calculus patient's 12 examples, ureteral calculus 12 examples, vesical calculus 11 examples, calculus of urethra 10 examples, urethritis 2 examples, cystitis 2 examples, prostatitis 3 examples.
Usage and dosage: three times on the one, one time nine gram, half an hour ante cibum warm water delivery service.15 is a course of treatment.Continue after the remission to take medicine and consolidate curative effect a course of treatment.
Irritable food such as period in a medicine is quitted smoking, the pungent work heat of wine and polydipsia water, multi-activity are beneficial to calculus and discharge.Be not taken by pregnant women, the old man child is cut down according to the circumstance.
Therapeutic effect: 52 routine clinical patients are being taken all recoveries from illness after three courses of treatment of this medicine continuously, and do not see recurrence so far.
Embodiment 4:
The component that the prescription of pharmaceutical composition that present embodiment adopts comprises and the weight portion of each component are as follows:
Herba Lysimachiae 30; holds 18; Caulis Akebiae 9; Rhizoma Alismatis 13;
Semen Plantaginis 15; Semen Abutili 9; Herba Taraxaci 33; Herba Dianthi 13;
Talcum 30; Spora Lygodii 15; Herba Artemisiae Anomalae 13; Succinum 15;
Radix Achyranthis Bidentatae 18; Olibanum 7; Endothelium Corneum Gigeriae Galli 9; Catharsii molossi 3;
Semen Vaccariae 15; Carapax Trionycis 18.
According to the weight portion weighing medical material of each component in the prescription, grind the back and mix, adopt the conventional method of Chinese medicine preparation to be prepared into tablet, every 3 gram.
The clinical patients statistics: the powder agent medicine that utilizes present embodiment to provide is treated 60 routine patients, and all patients all make a definite diagnosis through hospital.Wherein, renal calculus patient's 18 examples, ureteral calculus 12 examples, vesical calculus 13 examples, calculus of urethra 10 examples, urethritis 2 examples, cystitis 2 examples, prostatitis 3 examples.
Usage and dosage: three times on the one, one time nine gram, half an hour ante cibum warm water delivery service.15 is a course of treatment.Continue after the remission to take medicine and consolidate curative effect a course of treatment.
Irritable food such as period in a medicine is quitted smoking, the pungent work heat of wine and polydipsia water, multi-activity are beneficial to calculus and discharge.Be not taken by pregnant women, the old man child is cut down according to the circumstance.
Therapeutic effect: 60 routine clinical patients are being taken all recoveries from illness after three courses of treatment of this medicine continuously, and do not see recurrence so far.
Model case is given an example:
Case 1: Tan Dazhong, the man 32 years old, lives Enshi City Gong Long township.
The state of an illness: suffered from the calculus of urethra disease in 1999, the radiation of stomachache traction umbilicus Zhou Bingxiang perineum, paroxysmal aggravate unbearably, and companion's urine is anxious frequently, and the puckery pain hematuria of holding concurrently is vexed disgusting.
Treatment: the pharmaceutical composition of taking the present invention's proposition is after 5 days, and urine is discharged one piece as Semen sojae atricolor sample calculus, consolidates sick announcement of curative effect the week of continuing to take medicine and fully recovers, recurrence so far.
Case 2: Cui Xingyu, the man 58 years old, lives Enshi City Cui dam community.
The state of an illness: suffered from calculus in 2000, disease is seen the aggravation of waist abdomen pain companion paroxysmal, hold concurrently heating, frequent micturition, urgent micturition, puckery pain hematuria, sagging distention in the smaller abdomen, dysuria.
Treatment: take the pharmaceutical composition 7 days that the present invention proposes, discharge, consolidate curative effect the course of treatment of continuing to take medicine, recur so far as one piece in Semen arachidis hypogaeae sample calculus.
Case 3: south is brave, and the man 31 years old, lives Enshi City Cui Ba town.
The state of an illness: calendar year 2001 December 7 days, because of waist angina abdominis companion radiation sense appears in sudden onset, double urine is urgency, the puckery pain of defecation, vexed disgusting frequently, to the ultrasound diagnosis of local hospital, see that right kidney aggregation system luminous point group separates 1.3cm, right side ureter epimere is seen 0.6cm * 0.4cm calculus light group, prompting right ureter epimere calculus and right renal pelvis hydrops.
Treatment: take medicine of the present invention after course of treatment all diseases disappear, continue to take and consolidate curative effect a course of treatment, so far recurrence.
Case 4: Cui Xiaohai, the man 32 years old, lives Enshi City Cui Ba town.
The state of an illness: 2002, because of waist abdomen pain companion paroxysmal increases the weight of, the frequent micturition of holding concurrently, urgent micturition, Urethra astringent pain, vexed disgusting found that to hospital's ultrasound diagnosis left kidney has calculus light group and the slight hydrops of renal pelvis.
Treatment: take pharmaceutical composition of the present invention after 4 days, in the 5:00 AM clock, the bloated sense of feel urine obviously increases the weight of, and discharges greater than one piece in Semen phaseoli radiati shape calculus when exerting oneself defecation, and it is comfortable that health is felt immediately, continues to take medicine and consolidated curative effect in 7 days, recurs so far.
Case 5: Wu Zehan, the man 35 years old, lives Xia Ba township, Jianshi County.
The state of an illness: suffered from calculus in 2004, left side waist and belly pain, middle lower abdominal pain is violent, companion's frequent micturition, urgent micturition, yellowish or reddish urine, the puckery pain of pouring drop, nauseating disgusting.
Treatment: take pharmaceutical composition of the present invention transference cure after course of treatment, continue to take a week and consolidate curative effect, so far recurrence.
Claims (6)
1. a pharmaceutical composition is characterized in that, the component that comprises and the weight portion of each component are as follows:
Herba Lysimachiae 27-33; Herba Polygoni Avicularis 12-18; Caulis Akebiae 3-9; Rhizoma Alismatis 7-13;
Semen Plantaginis 9-15; Semen Abutili 7-13; Herba Taraxaci 27-33; Herba Dianthi 7-13;
Talcum 27-33; Spora Lygodii 9-15; Herba Artemisiae Anomalae 9-15; Succinum 9-15;
Radix Achyranthis Bidentatae 12-18; Olibanum 7-13; Endothelium Corneum Gigeriae Galli 9-15; Catharsii molossi 3-9;
Semen Vaccariae 9-15; Carapax Trionycis 12-18.
2. pharmaceutical composition according to claim 1 is characterized in that, the component that comprises and the weight portion of each component are as follows:
Herba Lysimachiae 30; Herba Polygoni Avicularis 15; Caulis Akebiae 6; Rhizoma Alismatis 10;
Semen Plantaginis 12; Semen Abutili 10; Herba Taraxaci 30; Herba Dianthi 10;
Talcum 30; Spora Lygodii 12; Herba Artemisiae Anomalae 12; Succinum 12;
Radix Achyranthis Bidentatae 15; Olibanum 10; Endothelium Corneum Gigeriae Galli 12; Catharsii molossi 6;
Semen Vaccariae 12; Carapax Trionycis 15.
3. the described preparation of drug combination method of claim 1 is as follows:
After grinding, each component of getting following weight portion is mixed and made into suitable dosage form,
Herba Lysimachiae 27-33; Herba Polygoni Avicularis 12-18; Caulis Akebiae 3-9; Rhizoma Alismatis 7-13;
Semen Plantaginis 9-15; Semen Abutili 7-13; Herba Taraxaci 27-33; Herba Dianthi 7-13;
Talcum 27-33; Spora Lygodii 9-15; Herba Artemisiae Anomalae 9-15; Succinum 9-15;
Radix Achyranthis Bidentatae 12-18; Olibanum 7-13; Endothelium Corneum Gigeriae Galli 9-15; Catharsii molossi 3-9;
Semen Vaccariae 9-15; Carapax Trionycis 12-18.
4. according to the described preparation of drug combination method of claim 3, it is characterized in that described preparation method is as follows: after grinding, each component of getting following weight portion is mixed and made into suitable dosage form,
Herba Lysimachiae 30; Herba Polygoni Avicularis 15; Caulis Akebiae 6; Rhizoma Alismatis 10;
Semen Plantaginis 12; Semen Abutili 10; Herba Taraxaci 30; Herba Dianthi 10;
Talcum 30; Spora Lygodii 12; Herba Artemisiae Anomalae 12; Succinum 12;
Radix Achyranthis Bidentatae 15; Olibanum 10; Endothelium Corneum Gigeriae Galli 12; Catharsii molossi 6;
Semen Vaccariae 12; Carapax Trionycis 15.
5. according to claim 3 or 4 described preparation of drug combination methods, it is characterized in that described dosage form can be any in tablet, powder, capsule and the pill.
6. claim 1 or the application of 2 described pharmaceutical compositions in renal calculus, ureteral calculus, vesical calculus, calculus of urethra and urethritis, cystitis, prostatitic treatment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100587675A CN100344306C (en) | 2006-03-06 | 2006-03-06 | Medicine composition for treating urinary system stone and inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100587675A CN100344306C (en) | 2006-03-06 | 2006-03-06 | Medicine composition for treating urinary system stone and inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1850220A true CN1850220A (en) | 2006-10-25 |
| CN100344306C CN100344306C (en) | 2007-10-24 |
Family
ID=37131732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100587675A Expired - Fee Related CN100344306C (en) | 2006-03-06 | 2006-03-06 | Medicine composition for treating urinary system stone and inflammation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100344306C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101703746B (en) * | 2009-11-19 | 2011-06-22 | 成都中医药大学 | Medicinal composition for treating prostatitis and preparation method thereof |
| CN103223060A (en) * | 2013-03-11 | 2013-07-31 | 安徽圣芝堂生物科技有限公司 | Traditional Chinese medicine for treating prostatosis |
| CN104027654A (en) * | 2014-06-30 | 2014-09-10 | 刘翠玲 | Traditional Chinese medicine for treating qi stagnation and blood stasis type kidney calculi |
| CN104055902A (en) * | 2014-06-28 | 2014-09-24 | 张志红 | Traditional Chinese medicine composition for treating prostatitis |
| CN105878918A (en) * | 2014-12-17 | 2016-08-24 | 杨少梅 | Medicine for treating urinary calculus |
| CN106236979A (en) * | 2016-08-31 | 2016-12-21 | 余彬 | Paishi Tang |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1565608A (en) * | 2003-07-03 | 2005-01-19 | 北京亚科希药物研究所 | Botanical medicine for treating urinary system calculi, its compositions and preparing method |
| CN1255148C (en) * | 2003-12-26 | 2006-05-10 | 喻建平 | Chinese medicine for treating urolithiasis and its preparing method |
-
2006
- 2006-03-06 CN CNB2006100587675A patent/CN100344306C/en not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101703746B (en) * | 2009-11-19 | 2011-06-22 | 成都中医药大学 | Medicinal composition for treating prostatitis and preparation method thereof |
| CN103223060A (en) * | 2013-03-11 | 2013-07-31 | 安徽圣芝堂生物科技有限公司 | Traditional Chinese medicine for treating prostatosis |
| CN103223060B (en) * | 2013-03-11 | 2014-06-18 | 安徽圣芝堂生物科技有限公司 | Traditional Chinese medicine for treating prostatosis |
| CN104055902A (en) * | 2014-06-28 | 2014-09-24 | 张志红 | Traditional Chinese medicine composition for treating prostatitis |
| CN104055902B (en) * | 2014-06-28 | 2016-08-17 | 张志红 | One treats prostatitic Chinese medicine composition |
| CN104027654A (en) * | 2014-06-30 | 2014-09-10 | 刘翠玲 | Traditional Chinese medicine for treating qi stagnation and blood stasis type kidney calculi |
| CN105878918A (en) * | 2014-12-17 | 2016-08-24 | 杨少梅 | Medicine for treating urinary calculus |
| CN106236979A (en) * | 2016-08-31 | 2016-12-21 | 余彬 | Paishi Tang |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100344306C (en) | 2007-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100344306C (en) | Medicine composition for treating urinary system stone and inflammation | |
| CN1840151A (en) | Pure Chinese medicinal preparation for activating blood circulation, removing blood stasis and relieving pain | |
| CN102670928B (en) | Plaster for treating cervical spondylosis and lumbar spondylosis | |
| CN1190217C (en) | Medicine for treating dematosis | |
| CN1698748A (en) | Externally applied pure Chinese medicine for treating spondylitis ankylopoietica and arthritis and its preparation method | |
| CN1853664A (en) | Medicinal composition for treating wound and preparation thereof | |
| CN1785325A (en) | Ready prepared Chinese medicine for treating acute, chronic prostatitis and its preparation method | |
| CN1883666A (en) | Pharmaceutical composition for treating nephritis | |
| CN1290548C (en) | Traditional Chinese medicine for curing bone fracture and rheumatic diseases | |
| CN1864730A (en) | A cancer-treating medicine | |
| CN1179726C (en) | Application of naringin in preparing medicine for supporting treatment of SARS | |
| CN1628771A (en) | Lotion for treating gynecological disease and its preparation process | |
| CN1706452A (en) | Medicine for treating chronic prostatitis and its prepn process | |
| CN1931298A (en) | Medicine for treating wind-damp arthralgia and hyperosteogeny | |
| CN1186067C (en) | Medicine for curing acute injury of muscle and tendon and its preparation method | |
| CN1272030C (en) | Chinese traditional medicine for treating pain of neck, shoulder, waist and leg and preparation method thereof | |
| CN102423479B (en) | Externally applied Chinese medicinal ointment for treating bedsores and its preparation method | |
| CN1260973A (en) | Health-care tea pillow | |
| CN1243565C (en) | Traditional Chinese medicine pain-relieving bag | |
| CN1843441A (en) | Rheumatism-eliminating collaterals-dredging externally applied plaster | |
| CN1730091A (en) | Medicine for curing lithangiuria | |
| CN1241626C (en) | Traditional Chinese medicine composition for treating rheumatic arthritis and atrophic arthritis | |
| CN1544019A (en) | Chinese traditional medicine composition for treating arthralgia syndrome of cervical spondylopathy and its preparation | |
| CN1192365A (en) | Traditional Chinese medicine for treating mastosis | |
| CN1313117C (en) | Chinese medicine external applied powder for bone damage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20071024 Termination date: 20130306 |